Development, Evaluation and Stability Studies of Zidovudine and Lamivudine (ZILA) Tablet Dosage Form

Singh, Vikramjit; Alam, Nawazish; Sharma, Monika; Alam, Sarfaraz; Ali, Sajid; Alam, Intakhab
September 2012
Journal of Applied Pharmaceutical Science;Sep2012, Vol. 2 Issue 9, p149
Academic Journal
Tablets containing zidovudine and lamivudine (ZILA) were prepared by direct compression method. Optimization studies were done for the selection of glidant, lubricant and coating materials. Evaluation of granuleswere done on the basis of preformulation studies. The prepared tablets were evaluated for physicochemical properties. The in- vitro release studies were performed as per USP and compared with marketed product. The release of zidovudine and lamivudine were analysed by high performance liquid chromatography (HPLC). The ZILA tablets exhibited better release characteristics than the marketed product. Stabilities studies were performed in both blister as well as cold form blister packings. Stabilities studies revealed the suitability of blister package in comparison to the cold form blister packing. From the study it was concluded that the selected composition can be used for the preparation of tablets that can be used for the treatment of HIV-1 and Hepatitis-B after performing studies on animals for its suitability and efficacy.


Related Articles

  • Mouth Dissolving Tablets II: An Overview of Evaluation Techniques. Shukla, Dali; Chakraborty, Subhashis; Singh, Sanjay; Mishra, Brahmeshwar // Scientia Pharmaceutica;Jun2009, Vol. 77 Issue 2, p327 

    Mouth dissolving tablets are well established dosage forms available in the market. The numerous advantages that they offer to the patients in terms of compliance as well as to the manufacturers in terms of huge revenues by line extension of products are well known. In spite of such popularity,...

  • reverse transcriptase inhibitors. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p663 

    An encyclopedia entry for "reverse transcriptase inhibitors" is presented. They refer to a class of drugs used for treating certain infectious diseases, including HIV infection and hepatitis B infection. These inhibitors affect the ability of the virus to reproduce by blocking reverse...

  • Amodiaquine hydrochloride tablets.  // WHO Drug Information;2007, Vol. 21 Issue 3, p212 

    The article provides an overview of the draft proposal for the development of Amodiaquine hydrochloride tablets. It is categorized as an antimalarial drugs and should be stored in a well-closed container. It stated that the designation of its container should indicate that the active ingredient...

  • Formulation Development of Efavirenz Tablets Employing β Cyclodextrin, Solutol HS15 and PVP K30. Ramana, D. Venkata; Chowdary, K. P. R. // Journal of Pharmacy Research;2012, Vol. 5 Issue 3, p1320 

    Efavirenz, a widely prescribed anti retroviral drug belongs to class II under BCS and exhibits low and variable oral bioavailability due to its poor aqueous solubility. Its oral absorption is dissolution rate limited and it requires enhancement in the solubility and dissolution rate for...

  • Trials of oral hepatitis B drug grind to a halt.  // Drug Topics;7/19/93, Vol. 137 Issue 14, p5 

    Reports on the interruption of clinical studies involving fialuridine, an oral agent in development for the treatment of hepatitis B. Problems noted; Development by Eli Lilly & Company.

  • Development and Validation of HPTLC Method for the Estimation of Almotriptan Malate in Tablet Dosage Form. SUNEETHA, A.; SYAMASUNDAR, B. // Indian Journal of Pharmaceutical Sciences;Sep/Oct2010, Vol. 72 Issue 5, p629 

    A new, simple, precise and accurate high performance thin layer chromatographic method has been proposed for the determination of almotriptan malate in a tablet dosage form. The drug was separated on aluminum plates precoated with silica gel 60 GF254 with butanol:acetic acid:water (3:1:1) was...

  • 3TC QUESTIONED IN HEPATITIS.  // AIDS Patient Care & STDs;Mar1999, Vol. 13 Issue 3, p199 

    Reports that Swiss physicians are questioning the use of once-a-day regimens of lamivudine as treatment for hepatitis B. Physicians' recommendation of the use of twice-daily regimens; Pharmacokinetics of lamivudine.

  • An indirect Spectrophotometric Methods for the estimation of Lamivudine in pure and tablet dosage form. Chaithanya, K.; Padma, A.; Swapna, A.; Rani, K.Swaroopa; Ramalingam, P. // International Journal of ChemTech Research;Apr-Jun2011, Vol. 3 Issue 2, p733 

    Lamivudine is an antiviral drug. Two simple, rapid and sensitive colorimetric methods have been developed for Lamivudine in pharmaceutical formulations. Method A is based on the formation of oxidativecoupling reaction involving the use of iron (III)-MBTH (3-methyl-2-benzothiazolinone hydrazone...

  • VALIDATED SPECTROPHOTOMETRIC ESTIMATION OF LAMIVUDINE IN PURE AND TABLET DOSAGE FORM. Babu, C. Jose Gnana; Kumar, G. Vijaya // International Journal of PharmTech Research;Oct-Dec2009, Vol. 1 Issue 4, p1372 

    Two simple and sensitive spectrophotometric methods have been developed for the estimation of Lamivudine in both pure and tablet dosage form. Methods A and B are based on the condensation reaction of Lamivudine with carbonyl reagents such as p-dimethylaminobenzaldehyde (PDAB) and vanillin in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics